Speaker illustration

Miss Lisa Pasterk

University of Zurich, Zurich (Switzerland)

Mechanism of ultra-low LDL-C and platelets- insights from Tangier disease patients and patients on PCSK9 inhibitor therapy

Event: ESC Congress 2018

Topic: Platelets, Haemostasis, Coagulation

Session: Vascular pathophysiology and thrombosis


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb